
The following have been reloaded with a version change:
  1) GCCcore/8.3.0 => GCCcore/9.3.0
  2) binutils/2.32-GCCcore-8.3.0 => binutils/2.34-GCCcore-9.3.0
  3) zlib/1.2.11-GCCcore-8.3.0 => zlib/1.2.11-GCCcore-9.3.0

2021-02-01 00:13:27 | INFO | fairseq_cli.train | Namespace(activation_dropout=0.0, activation_fn='relu', adam_betas='(0.9, 0.98)', adam_eps=1e-08, adaptive_input=False, adaptive_softmax_cutoff=None, adaptive_softmax_dropout=0, all_gather_list_size=16384, arch='transformer_vaswani_wmt_en_de_big', attention_dropout=0.0, best_checkpoint_metric='loss', bf16=False, bpe=None, broadcast_buffers=False, bucket_cap_mb=25, checkpoint_suffix='', clip_norm=0.0, cpu=False, criterion='label_smoothed_cross_entropy', cross_self_attention=False, curriculum=0, data='../../../data-bin/custom_EMEA/orig_EMEA', data_buffer_size=10, dataset_impl=None, ddp_backend='c10d', decoder_attention_heads=16, decoder_embed_dim=1024, decoder_embed_path=None, decoder_ffn_embed_dim=4096, decoder_input_dim=1024, decoder_layerdrop=0, decoder_layers=6, decoder_layers_to_keep=None, decoder_learned_pos=False, decoder_normalize_before=False, decoder_output_dim=1024, device_id=0, disable_validation=False, distributed_backend='nccl', distributed_init_method=None, distributed_no_spawn=False, distributed_port=-1, distributed_rank=0, distributed_world_size=1, distributed_wrapper='DDP', dropout=0.2, empty_cache_freq=0, encoder_attention_heads=16, encoder_embed_dim=1024, encoder_embed_path=None, encoder_ffn_embed_dim=8192, encoder_layerdrop=0, encoder_layers=6, encoder_layers_to_keep=None, encoder_learned_pos=False, encoder_normalize_before=False, eval_bleu=True, eval_bleu_args='{"beam": 5, "max_len_a": 1.2, "max_len_b": 10}', eval_bleu_detok='moses', eval_bleu_detok_args=None, eval_bleu_print_samples=True, eval_bleu_remove_bpe='@@ ', eval_tokenized_bleu=False, fast_stat_sync=False, find_unused_parameters=False, fix_batches_to_gpus=False, fixed_validation_seed=None, fp16=True, fp16_init_scale=128, fp16_no_flatten_grads=False, fp16_scale_tolerance=0.0, fp16_scale_window=None, keep_best_checkpoints=-1, keep_interval_updates=-1, keep_last_epochs=-1, label_smoothing=0.1, layernorm_embedding=False, left_pad_source='True', left_pad_target='False', load_alignments=False, localsgd_frequency=3, log_format=None, log_interval=100, lr=[0.000175], lr_scheduler='inverse_sqrt', max_epoch=40, max_sentences=None, max_sentences_valid=None, max_source_positions=1024, max_target_positions=1024, max_tokens=4096, max_tokens_valid=4096, max_update=0, maximize_best_checkpoint_metric=False, memory_efficient_bf16=False, memory_efficient_fp16=False, min_loss_scale=0.0001, min_lr=-1, model_parallel_size=1, no_cross_attention=False, no_epoch_checkpoints=True, no_last_checkpoints=False, no_progress_bar=False, no_save=False, no_save_optimizer_state=False, no_scale_embedding=False, no_seed_provided=True, no_token_positional_embeddings=False, nprocs_per_node=1, num_batch_buckets=0, num_workers=1, optimizer='adam', optimizer_overrides='{}', patience=-1, profile=False, quant_noise_pq=0, quant_noise_pq_block_size=8, quant_noise_scalar=0, quantization_config_path=None, required_batch_size_multiple=8, reset_dataloader=True, reset_lr_scheduler=False, reset_meters=False, reset_optimizer=True, restore_file='../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt', save_dir='../checkpoints/EMEA_19', save_interval=1, save_interval_updates=0, scoring='bleu', seed=1, sentence_avg=False, share_all_embeddings=False, share_decoder_input_output_embed=True, skip_invalid_size_inputs_valid_test=False, slowmo_algorithm='LocalSGD', slowmo_momentum=None, source_lang=None, stop_time_hours=0, target_lang=None, task='translation', tensorboard_logdir='', threshold_loss_scale=None, tie_adaptive_weights=False, tokenizer=None, tpu=False, train_subset='train', truncate_source=False, update_freq=[1], upsample_primary=1, use_bmuf=False, use_old_adam=False, user_dir=None, valid_subset='valid', validate_after_updates=0, validate_interval=1, validate_interval_updates=0, warmup_init_lr=-1, warmup_updates=4000, weight_decay=0.0)
2021-02-01 00:13:27 | INFO | fairseq.tasks.translation | [de] dictionary: 42024 types
2021-02-01 00:13:27 | INFO | fairseq.tasks.translation | [en] dictionary: 42024 types
2021-02-01 00:13:27 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.de
2021-02-01 00:13:28 | INFO | fairseq.data.data_utils | loaded 151 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/valid.de-en.en
2021-02-01 00:13:28 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA valid de-en 151 examples
2021-02-01 00:13:34 | INFO | fairseq_cli.train | TransformerModel(
  (encoder): TransformerEncoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerEncoderLayer(
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (dropout_module): FairseqDropout()
        (activation_dropout_module): FairseqDropout()
        (fc1): Linear(in_features=1024, out_features=8192, bias=True)
        (fc2): Linear(in_features=8192, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
  )
  (decoder): TransformerDecoder(
    (dropout_module): FairseqDropout()
    (embed_tokens): Embedding(42024, 1024, padding_idx=1)
    (embed_positions): SinusoidalPositionalEmbedding()
    (layers): ModuleList(
      (0): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (1): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (2): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (3): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (4): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
      (5): TransformerDecoderLayer(
        (dropout_module): FairseqDropout()
        (self_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (activation_dropout_module): FairseqDropout()
        (self_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (encoder_attn): MultiheadAttention(
          (dropout_module): FairseqDropout()
          (k_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (v_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (q_proj): Linear(in_features=1024, out_features=1024, bias=True)
          (out_proj): Linear(in_features=1024, out_features=1024, bias=True)
        )
        (encoder_attn_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
        (fc1): Linear(in_features=1024, out_features=4096, bias=True)
        (fc2): Linear(in_features=4096, out_features=1024, bias=True)
        (final_layer_norm): LayerNorm((1024,), eps=1e-05, elementwise_affine=True)
      )
    )
    (output_projection): Linear(in_features=1024, out_features=42024, bias=False)
  )
)
2021-02-01 00:13:34 | INFO | fairseq_cli.train | model transformer_vaswani_wmt_en_de_big, criterion LabelSmoothedCrossEntropyCriterion
2021-02-01 00:13:34 | INFO | fairseq_cli.train | num. model params: 312778752 (num. trained: 312778752)
2021-02-01 00:13:42 | INFO | fairseq.trainer | detected shared parameter: decoder.embed_tokens.weight <- decoder.output_projection.weight
2021-02-01 00:13:42 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 00:13:42 | INFO | fairseq.utils | rank   0: capabilities =  7.0  ; total memory = 32.000 GB ; name = GRID V100D-32Q                          
2021-02-01 00:13:42 | INFO | fairseq.utils | ***********************CUDA enviroments for all 1 workers***********************
2021-02-01 00:13:42 | INFO | fairseq_cli.train | training on 1 devices (GPUs/TPUs)
2021-02-01 00:13:42 | INFO | fairseq_cli.train | max tokens per GPU = 4096 and max sentences per GPU = None
2021-02-01 00:13:49 | INFO | fairseq.trainer | loaded checkpoint ../../../models/wmt19.de-en.joined-dict.ensemble//model1.pt (epoch 16 @ 0 updates)
2021-02-01 00:13:49 | INFO | fairseq.trainer | loading train data for epoch 1
2021-02-01 00:13:50 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.de
2021-02-01 00:13:50 | INFO | fairseq.data.data_utils | loaded 10001 examples from: ../../../data-bin/custom_EMEA/orig_EMEA/train.de-en.en
2021-02-01 00:13:50 | INFO | fairseq.tasks.translation | ../../../data-bin/custom_EMEA/orig_EMEA train de-en 10001 examples
2021-02-01 00:13:50 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 00:13:51 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 64.0
2021-02-01 00:13:51 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 32.0
2021-02-01 00:13:54 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 16.0
2021-02-01 00:13:55 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 8.0
2021-02-01 00:14:08 | INFO | train_inner | epoch 001:    104 / 139 loss=3.616, nll_loss=1.905, ppl=3.74, wps=14235.2, ups=5.77, wpb=2465.8, bsz=72.7, num_updates=100, lr=4.375e-06, gnorm=4.011, loss_scale=12, train_wall=17, wall=27
2021-02-01 00:14:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:14:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which can cause allergic reactions.
2021-02-01 00:14:16 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:14:17 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used together with long acting insulin preparations.
2021-02-01 00:14:17 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:14:18 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy A rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:14:18 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:14:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .The studies compared actrapid to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood sugar is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with actrapid.
2021-02-01 00:14:21 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:14:21 | INFO | valid | epoch 001 | valid on 'valid' subset | loss 3.716 | nll_loss 1.989 | ppl 3.97 | bleu 36.14 | wps 761.8 | wpb 1083 | bsz 37.8 | num_updates 135
2021-02-01 00:14:21 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:14:39 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 1 @ 135 updates, score 3.716) (writing took 18.11719050910324 seconds)
2021-02-01 00:14:39 | INFO | fairseq_cli.train | end of epoch 1 (average epoch stats below)
2021-02-01 00:14:39 | INFO | train | epoch 001 | loss 3.574 | nll_loss 1.861 | ppl 3.63 | wps 6924.5 | ups 2.82 | wpb 2458.9 | bsz 72.3 | num_updates 135 | lr 5.90625e-06 | gnorm 3.898 | loss_scale 12 | train_wall 24 | wall 57
2021-02-01 00:14:39 | INFO | fairseq_cli.train | begin training epoch 1
2021-02-01 00:14:50 | INFO | train_inner | epoch 002:     65 / 139 loss=3.401, nll_loss=1.674, ppl=3.19, wps=5971.7, ups=2.4, wpb=2487.4, bsz=75, num_updates=200, lr=8.75e-06, gnorm=3.334, loss_scale=8, train_wall=17, wall=68
2021-02-01 00:15:03 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:15:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:15:03 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:15:04 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-02-01 00:15:04 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:15:05 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Occasional - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with symptoms known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:15:05 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:15:07 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two studies with 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one study with 182 patients) .In the studies, Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c) indicating how well the blood glucose is regulated.What benefit has actrapid shown in these studies? Concentrations of HbA1c remained relatively stable during the 6-month treatment with Actrapid.
2021-02-01 00:15:07 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:15:07 | INFO | valid | epoch 002 | valid on 'valid' subset | loss 3.4 | nll_loss 1.623 | ppl 3.08 | bleu 41.25 | wps 902.3 | wpb 1083 | bsz 37.8 | num_updates 274 | best_loss 3.4
2021-02-01 00:15:07 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:15:26 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 2 @ 274 updates, score 3.4) (writing took 19.171970915049314 seconds)
2021-02-01 00:15:26 | INFO | fairseq_cli.train | end of epoch 2 (average epoch stats below)
2021-02-01 00:15:26 | INFO | train | epoch 002 | loss 3.337 | nll_loss 1.597 | ppl 3.03 | wps 7209.3 | ups 2.93 | wpb 2458.3 | bsz 71.9 | num_updates 274 | lr 1.19875e-05 | gnorm 3.246 | loss_scale 8 | train_wall 23 | wall 104
2021-02-01 00:15:26 | INFO | fairseq_cli.train | begin training epoch 2
2021-02-01 00:15:31 | INFO | train_inner | epoch 003:     26 / 139 loss=3.285, nll_loss=1.535, ppl=2.9, wps=5757.1, ups=2.47, wpb=2333, bsz=67, num_updates=300, lr=1.3125e-05, gnorm=3.217, loss_scale=8, train_wall=17, wall=109
2021-02-01 00:15:48 | INFO | train_inner | epoch 003:    126 / 139 loss=3.088, nll_loss=1.31, ppl=2.48, wps=14888.4, ups=5.87, wpb=2535.2, bsz=75.8, num_updates=400, lr=1.75e-05, gnorm=2.972, loss_scale=8, train_wall=17, wall=126
2021-02-01 00:15:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:15:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:15:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:15:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-02-01 00:15:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:15:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:15:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:15:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes in which the pancreas is unable to produce insulin (two trials involving 1,954 patients) and in patients with type 2 diabetes in which the body is unable to process insulin effectively (one trial involving 182 patients) .The trials compared Actrapid to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is regulated.What benefit has Actrapid shown in these trials? HbA1c concentrations have remained relatively stable during the 6 months of treatment with Actrapid.
2021-02-01 00:15:55 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:15:55 | INFO | valid | epoch 003 | valid on 'valid' subset | loss 3.143 | nll_loss 1.325 | ppl 2.51 | bleu 47.86 | wps 866.7 | wpb 1083 | bsz 37.8 | num_updates 413 | best_loss 3.143
2021-02-01 00:15:55 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:16:14 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 3 @ 413 updates, score 3.143) (writing took 18.9021613933146 seconds)
2021-02-01 00:16:14 | INFO | fairseq_cli.train | end of epoch 3 (average epoch stats below)
2021-02-01 00:16:14 | INFO | train | epoch 003 | loss 3.1 | nll_loss 1.324 | ppl 2.5 | wps 7223.3 | ups 2.94 | wpb 2458.3 | bsz 71.9 | num_updates 413 | lr 1.80687e-05 | gnorm 2.917 | loss_scale 8 | train_wall 23 | wall 152
2021-02-01 00:16:14 | INFO | fairseq_cli.train | begin training epoch 3
2021-02-01 00:16:29 | INFO | train_inner | epoch 004:     87 / 139 loss=2.872, nll_loss=1.064, ppl=2.09, wps=6217.8, ups=2.45, wpb=2538.2, bsz=71, num_updates=500, lr=2.1875e-05, gnorm=2.427, loss_scale=8, train_wall=17, wall=167
2021-02-01 00:16:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:16:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:16:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:16:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast acting insulin and can be used in conjunction with long acting insulin preparations.
2021-02-01 00:16:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:16:39 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Rapid improvement in blood glucose control may be associated with conditions known as acute painful neuropathy, which are usually reversible.
2021-02-01 00:16:39 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:16:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body is unable to process insulin effectively (a study involving 182 patients), in which Actrapid was compared to a human insulin analogue (Insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-02-01 00:16:42 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:16:42 | INFO | valid | epoch 004 | valid on 'valid' subset | loss 2.941 | nll_loss 1.084 | ppl 2.12 | bleu 54.77 | wps 973.3 | wpb 1083 | bsz 37.8 | num_updates 552 | best_loss 2.941
2021-02-01 00:16:42 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:17:02 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 4 @ 552 updates, score 2.941) (writing took 20.358242857269943 seconds)
2021-02-01 00:17:02 | INFO | fairseq_cli.train | end of epoch 4 (average epoch stats below)
2021-02-01 00:17:02 | INFO | train | epoch 004 | loss 2.888 | nll_loss 1.081 | ppl 2.12 | wps 7075 | ups 2.88 | wpb 2458.3 | bsz 71.9 | num_updates 552 | lr 2.415e-05 | gnorm 2.544 | loss_scale 8 | train_wall 23 | wall 200
2021-02-01 00:17:02 | INFO | fairseq_cli.train | begin training epoch 4
2021-02-01 00:17:10 | INFO | train_inner | epoch 005:     48 / 139 loss=2.817, nll_loss=0.999, ppl=2, wps=5767.5, ups=2.39, wpb=2411.9, bsz=72.3, num_updates=600, lr=2.625e-05, gnorm=2.448, loss_scale=8, train_wall=17, wall=209
2021-02-01 00:17:26 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:17:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:17:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:17:27 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:17:27 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:17:28 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with conditions known as acute painful neuropathy, which is usually reversible.
2021-02-01 00:17:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:17:30 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two trials involving 1,954 patients), and in patients with type 2 diabetes, in which the body cannot process insulin effectively (one trial involving 182 patients), in which Actrapid was compared to a human insulin analogue (insulin aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-02-01 00:17:30 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:17:30 | INFO | valid | epoch 005 | valid on 'valid' subset | loss 2.783 | nll_loss 0.894 | ppl 1.86 | bleu 63.78 | wps 956.6 | wpb 1083 | bsz 37.8 | num_updates 691 | best_loss 2.783
2021-02-01 00:17:30 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:17:49 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 5 @ 691 updates, score 2.783) (writing took 18.632402010262012 seconds)
2021-02-01 00:17:49 | INFO | fairseq_cli.train | end of epoch 5 (average epoch stats below)
2021-02-01 00:17:49 | INFO | train | epoch 005 | loss 2.7 | nll_loss 0.866 | ppl 1.82 | wps 7326.8 | ups 2.98 | wpb 2458.3 | bsz 71.9 | num_updates 691 | lr 3.02312e-05 | gnorm 2.257 | loss_scale 8 | train_wall 23 | wall 247
2021-02-01 00:17:49 | INFO | fairseq_cli.train | begin training epoch 5
2021-02-01 00:17:50 | INFO | train_inner | epoch 006:      9 / 139 loss=2.686, nll_loss=0.85, ppl=1.8, wps=6081.6, ups=2.52, wpb=2415.5, bsz=69.1, num_updates=700, lr=3.0625e-05, gnorm=2.342, loss_scale=8, train_wall=17, wall=248
2021-02-01 00:18:07 | INFO | train_inner | epoch 006:    109 / 139 loss=2.531, nll_loss=0.676, ppl=1.6, wps=14729.5, ups=5.83, wpb=2527.8, bsz=73.9, num_updates=800, lr=3.5e-05, gnorm=1.884, loss_scale=8, train_wall=17, wall=265
2021-02-01 00:18:12 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:18:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:18:13 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:18:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-02-01 00:18:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:18:15 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in glycaemic control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:18:15 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:18:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, in which the pancreas is unable to produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, in which the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:18:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:18:16 | INFO | valid | epoch 006 | valid on 'valid' subset | loss 2.714 | nll_loss 0.812 | ppl 1.76 | bleu 73.43 | wps 979.5 | wpb 1083 | bsz 37.8 | num_updates 830 | best_loss 2.714
2021-02-01 00:18:16 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:18:37 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 6 @ 830 updates, score 2.714) (writing took 20.491308671422303 seconds)
2021-02-01 00:18:37 | INFO | fairseq_cli.train | end of epoch 6 (average epoch stats below)
2021-02-01 00:18:37 | INFO | train | epoch 006 | loss 2.541 | nll_loss 0.686 | ppl 1.61 | wps 7060.9 | ups 2.87 | wpb 2458.3 | bsz 71.9 | num_updates 830 | lr 3.63125e-05 | gnorm 1.957 | loss_scale 8 | train_wall 23 | wall 295
2021-02-01 00:18:37 | INFO | fairseq_cli.train | begin training epoch 6
2021-02-01 00:18:49 | INFO | train_inner | epoch 007:     70 / 139 loss=2.494, nll_loss=0.633, ppl=1.55, wps=5570.2, ups=2.41, wpb=2306.6, bsz=69, num_updates=900, lr=3.9375e-05, gnorm=1.883, loss_scale=8, train_wall=16, wall=307
2021-02-01 00:19:01 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:19:01 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:19:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:19:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:19:02 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:19:03 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:19:03 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:19:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapid has been studied in patients with type 1 diabetes, in which the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, in which the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:19:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:19:05 | INFO | valid | epoch 007 | valid on 'valid' subset | loss 2.67 | nll_loss 0.761 | ppl 1.69 | bleu 77.07 | wps 938.2 | wpb 1083 | bsz 37.8 | num_updates 969 | best_loss 2.67
2021-02-01 00:19:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:19:28 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 7 @ 969 updates, score 2.67) (writing took 22.895087033510208 seconds)
2021-02-01 00:19:28 | INFO | fairseq_cli.train | end of epoch 7 (average epoch stats below)
2021-02-01 00:19:28 | INFO | train | epoch 007 | loss 2.425 | nll_loss 0.556 | ppl 1.47 | wps 6700 | ups 2.73 | wpb 2458.3 | bsz 71.9 | num_updates 969 | lr 4.23937e-05 | gnorm 1.728 | loss_scale 8 | train_wall 23 | wall 346
2021-02-01 00:19:28 | INFO | fairseq_cli.train | begin training epoch 7
2021-02-01 00:19:33 | INFO | train_inner | epoch 008:     31 / 139 loss=2.384, nll_loss=0.511, ppl=1.42, wps=5787.6, ups=2.24, wpb=2584.4, bsz=78.4, num_updates=1000, lr=4.375e-05, gnorm=1.525, loss_scale=8, train_wall=17, wall=351
2021-02-01 00:19:50 | INFO | train_inner | epoch 008:    131 / 139 loss=2.338, nll_loss=0.458, ppl=1.37, wps=14448.4, ups=5.89, wpb=2451.8, bsz=69.4, num_updates=1100, lr=4.8125e-05, gnorm=1.545, loss_scale=8, train_wall=17, wall=368
2021-02-01 00:19:52 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:19:52 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:19:52 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:19:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:19:53 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:19:54 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:19:54 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:19:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, where the pancreas cannot produce insulin (two trials involving 1,954 patients), and in type 2 diabetes, where the body cannot process insulin effectively (a trial involving 182 patients) .The trials compared Actrapide with a human insulin analogue (insulin Aspart) by measuring the concentration in the blood of a substance called glycosylated haemoglobin (HbA1c), which indicates how well the blood glucose is controlled, for six months.
2021-02-01 00:19:56 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:19:56 | INFO | valid | epoch 008 | valid on 'valid' subset | loss 2.661 | nll_loss 0.748 | ppl 1.68 | bleu 79.58 | wps 936.9 | wpb 1083 | bsz 37.8 | num_updates 1108 | best_loss 2.661
2021-02-01 00:19:56 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:20:14 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 8 @ 1108 updates, score 2.661) (writing took 17.51942523289472 seconds)
2021-02-01 00:20:14 | INFO | fairseq_cli.train | end of epoch 8 (average epoch stats below)
2021-02-01 00:20:14 | INFO | train | epoch 008 | loss 2.337 | nll_loss 0.458 | ppl 1.37 | wps 7497.8 | ups 3.05 | wpb 2458.3 | bsz 71.9 | num_updates 1108 | lr 4.8475e-05 | gnorm 1.586 | loss_scale 8 | train_wall 23 | wall 392
2021-02-01 00:20:14 | INFO | fairseq_cli.train | begin training epoch 8
2021-02-01 00:20:29 | INFO | train_inner | epoch 009:     92 / 139 loss=2.284, nll_loss=0.401, ppl=1.32, wps=6163.5, ups=2.57, wpb=2396, bsz=67.8, num_updates=1200, lr=5.25e-05, gnorm=1.604, loss_scale=8, train_wall=17, wall=407
2021-02-01 00:20:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:20:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:20:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:20:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:20:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:20:40 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:20:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:20:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, in which the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, in which the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:20:42 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:20:42 | INFO | valid | epoch 009 | valid on 'valid' subset | loss 2.654 | nll_loss 0.738 | ppl 1.67 | bleu 78.65 | wps 956.1 | wpb 1083 | bsz 37.8 | num_updates 1247 | best_loss 2.654
2021-02-01 00:20:42 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:21:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_best.pt (epoch 9 @ 1247 updates, score 2.654) (writing took 29.77250170148909 seconds)
2021-02-01 00:21:11 | INFO | fairseq_cli.train | end of epoch 9 (average epoch stats below)
2021-02-01 00:21:11 | INFO | train | epoch 009 | loss 2.278 | nll_loss 0.395 | ppl 1.31 | wps 5907.5 | ups 2.4 | wpb 2458.3 | bsz 71.9 | num_updates 1247 | lr 5.45562e-05 | gnorm 1.445 | loss_scale 8 | train_wall 23 | wall 450
2021-02-01 00:21:11 | INFO | fairseq_cli.train | begin training epoch 9
2021-02-01 00:21:20 | INFO | train_inner | epoch 010:     53 / 139 loss=2.251, nll_loss=0.367, ppl=1.29, wps=4823.6, ups=1.95, wpb=2473.2, bsz=73.2, num_updates=1300, lr=5.6875e-05, gnorm=1.272, loss_scale=8, train_wall=17, wall=459
2021-02-01 00:21:35 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:21:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:21:36 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:21:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in combination with long-acting insulin preparations.
2021-02-01 00:21:36 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:21:37 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:21:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:21:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients whose pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes patients whose bodies cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:21:39 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:21:39 | INFO | valid | epoch 010 | valid on 'valid' subset | loss 2.664 | nll_loss 0.749 | ppl 1.68 | bleu 79.44 | wps 924.1 | wpb 1083 | bsz 37.8 | num_updates 1386 | best_loss 2.654
2021-02-01 00:21:39 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:21:45 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 10 @ 1386 updates, score 2.664) (writing took 5.732412047684193 seconds)
2021-02-01 00:21:45 | INFO | fairseq_cli.train | end of epoch 10 (average epoch stats below)
2021-02-01 00:21:45 | INFO | train | epoch 010 | loss 2.236 | nll_loss 0.351 | ppl 1.28 | wps 10094.2 | ups 4.11 | wpb 2458.3 | bsz 71.9 | num_updates 1386 | lr 6.06375e-05 | gnorm 1.355 | loss_scale 8 | train_wall 23 | wall 483
2021-02-01 00:21:45 | INFO | fairseq_cli.train | begin training epoch 10
2021-02-01 00:21:48 | INFO | train_inner | epoch 011:     14 / 139 loss=2.238, nll_loss=0.353, ppl=1.28, wps=9191.4, ups=3.67, wpb=2507.6, bsz=71.6, num_updates=1400, lr=6.125e-05, gnorm=1.455, loss_scale=8, train_wall=17, wall=486
2021-02-01 00:22:04 | INFO | train_inner | epoch 011:    114 / 139 loss=2.201, nll_loss=0.314, ppl=1.24, wps=14307.2, ups=5.97, wpb=2396.5, bsz=73.5, num_updates=1500, lr=6.5625e-05, gnorm=1.244, loss_scale=8, train_wall=17, wall=503
2021-02-01 00:22:09 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:22:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:22:09 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:22:10 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:22:10 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:22:11 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:22:11 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:22:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, where the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, where the body cannot process insulin effectively (a study involving 182 patients). The studies compared Actrapide with a human insulin analogue (insulin Aspart) by measuring in the blood a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled, for six months.
2021-02-01 00:22:14 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:22:14 | INFO | valid | epoch 011 | valid on 'valid' subset | loss 2.665 | nll_loss 0.759 | ppl 1.69 | bleu 77.99 | wps 730.5 | wpb 1083 | bsz 37.8 | num_updates 1525 | best_loss 2.654
2021-02-01 00:22:14 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:22:21 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 11 @ 1525 updates, score 2.665) (writing took 6.709373916499317 seconds)
2021-02-01 00:22:21 | INFO | fairseq_cli.train | end of epoch 11 (average epoch stats below)
2021-02-01 00:22:21 | INFO | train | epoch 011 | loss 2.205 | nll_loss 0.317 | ppl 1.25 | wps 9496.3 | ups 3.86 | wpb 2458.3 | bsz 71.9 | num_updates 1525 | lr 6.67187e-05 | gnorm 1.238 | loss_scale 8 | train_wall 23 | wall 519
2021-02-01 00:22:21 | INFO | fairseq_cli.train | begin training epoch 11
2021-02-01 00:22:34 | INFO | train_inner | epoch 012:     75 / 139 loss=2.179, nll_loss=0.292, ppl=1.22, wps=8591.3, ups=3.37, wpb=2547.2, bsz=72.2, num_updates=1600, lr=7e-05, gnorm=1.15, loss_scale=8, train_wall=17, wall=532
2021-02-01 00:22:45 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:22:46 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:22:46 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:22:47 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in conjunction with long-acting insulin preparations.
2021-02-01 00:22:47 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:22:48 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:22:48 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:22:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, when the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:22:50 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:22:50 | INFO | valid | epoch 012 | valid on 'valid' subset | loss 2.69 | nll_loss 0.792 | ppl 1.73 | bleu 79 | wps 874.9 | wpb 1083 | bsz 37.8 | num_updates 1664 | best_loss 2.654
2021-02-01 00:22:50 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:22:56 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 12 @ 1664 updates, score 2.69) (writing took 5.941717952489853 seconds)
2021-02-01 00:22:56 | INFO | fairseq_cli.train | end of epoch 12 (average epoch stats below)
2021-02-01 00:22:56 | INFO | train | epoch 012 | loss 2.177 | nll_loss 0.29 | ppl 1.22 | wps 9919 | ups 4.03 | wpb 2458.3 | bsz 71.9 | num_updates 1664 | lr 7.28e-05 | gnorm 1.144 | loss_scale 8 | train_wall 23 | wall 554
2021-02-01 00:22:56 | INFO | fairseq_cli.train | begin training epoch 12
2021-02-01 00:23:02 | INFO | train_inner | epoch 013:     36 / 139 loss=2.181, nll_loss=0.295, ppl=1.23, wps=8709, ups=3.61, wpb=2411.6, bsz=73.8, num_updates=1700, lr=7.4375e-05, gnorm=1.211, loss_scale=8, train_wall=17, wall=560
2021-02-01 00:23:19 | INFO | train_inner | epoch 013:    136 / 139 loss=2.15, nll_loss=0.261, ppl=1.2, wps=14502.5, ups=5.88, wpb=2466.8, bsz=70.3, num_updates=1800, lr=7.875e-05, gnorm=0.978, loss_scale=8, train_wall=17, wall=577
2021-02-01 00:23:19 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:23:20 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:23:20 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:23:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:23:21 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:23:22 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:23:22 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:23:24 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, when the body cannot process insulin effectively (a study of 182 patients), when Actrapide was compared with a human insulin analogue (insulin aspart) by measuring in the blood for six months the level of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:23:24 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:23:24 | INFO | valid | epoch 013 | valid on 'valid' subset | loss 2.715 | nll_loss 0.82 | ppl 1.77 | bleu 79.26 | wps 879.8 | wpb 1083 | bsz 37.8 | num_updates 1803 | best_loss 2.654
2021-02-01 00:23:24 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:23:30 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 13 @ 1803 updates, score 2.715) (writing took 5.797966830432415 seconds)
2021-02-01 00:23:30 | INFO | fairseq_cli.train | end of epoch 13 (average epoch stats below)
2021-02-01 00:23:30 | INFO | train | epoch 013 | loss 2.156 | nll_loss 0.268 | ppl 1.2 | wps 9994.4 | ups 4.07 | wpb 2458.3 | bsz 71.9 | num_updates 1803 | lr 7.88812e-05 | gnorm 1.08 | loss_scale 8 | train_wall 23 | wall 588
2021-02-01 00:23:30 | INFO | fairseq_cli.train | begin training epoch 13
2021-02-01 00:23:46 | INFO | train_inner | epoch 014:     97 / 139 loss=2.147, nll_loss=0.26, ppl=1.2, wps=9088.4, ups=3.61, wpb=2515.9, bsz=73, num_updates=1900, lr=8.3125e-05, gnorm=1.19, loss_scale=8, train_wall=17, wall=605
2021-02-01 00:23:54 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:23:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:23:54 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:23:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long- acting insulin preparations.
2021-02-01 00:23:55 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:23:56 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:23:56 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:23:58 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes when the body cannot process insulin effectively (a study involving 182 patients), when Actrapide was compared to an analogue human insulin (insulin aspart) by measuring in the blood for six months the level of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:23:58 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:23:58 | INFO | valid | epoch 014 | valid on 'valid' subset | loss 2.698 | nll_loss 0.816 | ppl 1.76 | bleu 79.05 | wps 898.4 | wpb 1083 | bsz 37.8 | num_updates 1942 | best_loss 2.654
2021-02-01 00:23:58 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:24:04 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 14 @ 1942 updates, score 2.698) (writing took 6.105747899971902 seconds)
2021-02-01 00:24:04 | INFO | fairseq_cli.train | end of epoch 14 (average epoch stats below)
2021-02-01 00:24:04 | INFO | train | epoch 014 | loss 2.144 | nll_loss 0.257 | ppl 1.19 | wps 9914.4 | ups 4.03 | wpb 2458.3 | bsz 71.9 | num_updates 1942 | lr 8.49625e-05 | gnorm 1.134 | loss_scale 8 | train_wall 23 | wall 622
2021-02-01 00:24:04 | INFO | fairseq_cli.train | begin training epoch 14
2021-02-01 00:24:14 | INFO | train_inner | epoch 015:     58 / 139 loss=2.132, nll_loss=0.245, ppl=1.19, wps=8774.8, ups=3.6, wpb=2439, bsz=72.1, num_updates=2000, lr=8.75e-05, gnorm=1.042, loss_scale=8, train_wall=17, wall=632
2021-02-01 00:24:28 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:24:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:24:29 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:24:30 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:24:30 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:24:31 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:24:31 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:24:33 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients whose pancreas cannot produce insulin (two studies involving 1,954 patients) and type 2 diabetic patients whose bodies cannot process insulin effectively (one study involving 182 patients).
2021-02-01 00:24:33 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:24:33 | INFO | valid | epoch 015 | valid on 'valid' subset | loss 2.709 | nll_loss 0.824 | ppl 1.77 | bleu 79.17 | wps 900.2 | wpb 1083 | bsz 37.8 | num_updates 2081 | best_loss 2.654
2021-02-01 00:24:33 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:24:39 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 15 @ 2081 updates, score 2.709) (writing took 6.23112905677408 seconds)
2021-02-01 00:24:39 | INFO | fairseq_cli.train | end of epoch 15 (average epoch stats below)
2021-02-01 00:24:39 | INFO | train | epoch 015 | loss 2.132 | nll_loss 0.246 | ppl 1.19 | wps 9840.9 | ups 4 | wpb 2458.3 | bsz 71.9 | num_updates 2081 | lr 9.10438e-05 | gnorm 1.041 | loss_scale 8 | train_wall 23 | wall 657
2021-02-01 00:24:39 | INFO | fairseq_cli.train | begin training epoch 15
2021-02-01 00:24:42 | INFO | train_inner | epoch 016:     19 / 139 loss=2.136, nll_loss=0.249, ppl=1.19, wps=8608, ups=3.56, wpb=2416.4, bsz=67.3, num_updates=2100, lr=9.1875e-05, gnorm=1.045, loss_scale=8, train_wall=17, wall=661
2021-02-01 00:24:59 | INFO | train_inner | epoch 016:    119 / 139 loss=2.122, nll_loss=0.236, ppl=1.18, wps=14673, ups=5.88, wpb=2496.3, bsz=74.5, num_updates=2200, lr=9.625e-05, gnorm=1.009, loss_scale=8, train_wall=17, wall=678
2021-02-01 00:25:03 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:25:03 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:25:03 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:25:04 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long- acting insulin preparations.
2021-02-01 00:25:04 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:25:06 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:25:06 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:25:08 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies with 1,954 patients), and in type 2 diabetes, when the body cannot process insulin effectively (a study with 182 patients) The studies compared Actrapide with a human insulin analogue (insulin aspart) by measuring the level in the blood of a substance termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled, for six months.
2021-02-01 00:25:08 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:25:08 | INFO | valid | epoch 016 | valid on 'valid' subset | loss 2.732 | nll_loss 0.85 | ppl 1.8 | bleu 76.8 | wps 872.7 | wpb 1083 | bsz 37.8 | num_updates 2220 | best_loss 2.654
2021-02-01 00:25:08 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:25:14 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 16 @ 2220 updates, score 2.732) (writing took 6.221092168241739 seconds)
2021-02-01 00:25:14 | INFO | fairseq_cli.train | end of epoch 16 (average epoch stats below)
2021-02-01 00:25:14 | INFO | train | epoch 016 | loss 2.125 | nll_loss 0.238 | ppl 1.18 | wps 9826.9 | ups 4 | wpb 2458.3 | bsz 71.9 | num_updates 2220 | lr 9.7125e-05 | gnorm 1.059 | loss_scale 8 | train_wall 23 | wall 692
2021-02-01 00:25:14 | INFO | fairseq_cli.train | begin training epoch 16
2021-02-01 00:25:27 | INFO | train_inner | epoch 017:     80 / 139 loss=2.123, nll_loss=0.238, ppl=1.18, wps=8659.3, ups=3.56, wpb=2431.2, bsz=67.6, num_updates=2300, lr=0.000100625, gnorm=1.062, loss_scale=8, train_wall=17, wall=706
2021-02-01 00:25:37 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:25:38 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:25:38 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:25:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:25:39 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:25:40 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:25:40 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:25:42 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, when the body cannot process insulin effectively (a study involving 182 patients). The studies compared Actrapide with a human insulin analogue (insulin aspart) by measuring the level of a substance termed glycosylated haemoglobin (HbA1c) in the blood for six months, which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:25:42 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:25:42 | INFO | valid | epoch 017 | valid on 'valid' subset | loss 2.731 | nll_loss 0.859 | ppl 1.81 | bleu 79.58 | wps 929.7 | wpb 1083 | bsz 37.8 | num_updates 2359 | best_loss 2.654
2021-02-01 00:25:42 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:25:48 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 17 @ 2359 updates, score 2.731) (writing took 5.8049175795167685 seconds)
2021-02-01 00:25:48 | INFO | fairseq_cli.train | end of epoch 17 (average epoch stats below)
2021-02-01 00:25:48 | INFO | train | epoch 017 | loss 2.121 | nll_loss 0.236 | ppl 1.18 | wps 10070.5 | ups 4.1 | wpb 2458.3 | bsz 71.9 | num_updates 2359 | lr 0.000103206 | gnorm 0.993 | loss_scale 8 | train_wall 23 | wall 726
2021-02-01 00:25:48 | INFO | fairseq_cli.train | begin training epoch 17
2021-02-01 00:25:55 | INFO | train_inner | epoch 018:     41 / 139 loss=2.12, nll_loss=0.235, ppl=1.18, wps=8992.1, ups=3.66, wpb=2457.9, bsz=79, num_updates=2400, lr=0.000105, gnorm=1.022, loss_scale=8, train_wall=17, wall=733
2021-02-01 00:26:11 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:26:12 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:26:12 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:26:13 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:26:13 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:26:14 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:26:14 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:26:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies of 1,954 patients), and in patients with type 2 diabetes, when the body cannot process insulin effectively (a study of 182 patients). The studies compared Actrapide with a human insulin analogue (insulin aspart), measuring in the blood for six months the level of a substance termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:26:16 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:26:16 | INFO | valid | epoch 018 | valid on 'valid' subset | loss 2.751 | nll_loss 0.881 | ppl 1.84 | bleu 77.5 | wps 851.2 | wpb 1083 | bsz 37.8 | num_updates 2498 | best_loss 2.654
2021-02-01 00:26:16 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:26:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 18 @ 2498 updates, score 2.751) (writing took 6.450602860189974 seconds)
2021-02-01 00:26:23 | INFO | fairseq_cli.train | end of epoch 18 (average epoch stats below)
2021-02-01 00:26:23 | INFO | train | epoch 018 | loss 2.119 | nll_loss 0.235 | ppl 1.18 | wps 9776.8 | ups 3.98 | wpb 2458.3 | bsz 71.9 | num_updates 2498 | lr 0.000109287 | gnorm 1.027 | loss_scale 8 | train_wall 23 | wall 761
2021-02-01 00:26:23 | INFO | fairseq_cli.train | begin training epoch 18
2021-02-01 00:26:23 | INFO | train_inner | epoch 019:      2 / 139 loss=2.117, nll_loss=0.234, ppl=1.18, wps=8613.3, ups=3.53, wpb=2439.4, bsz=69.4, num_updates=2500, lr=0.000109375, gnorm=0.98, loss_scale=8, train_wall=17, wall=761
2021-02-01 00:26:40 | INFO | train_inner | epoch 019:    102 / 139 loss=2.129, nll_loss=0.248, ppl=1.19, wps=14773.9, ups=5.8, wpb=2545.3, bsz=73.6, num_updates=2600, lr=0.00011375, gnorm=1.177, loss_scale=8, train_wall=17, wall=778
2021-02-01 00:26:46 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:26:47 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:26:47 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:26:48 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:26:48 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:26:49 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:26:49 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:26:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies of 1,954 patients), and in type 2 diabetes, when the body cannot process insulin effectively (a study of 182 patients) for six months, comparing Actrapide with a human insulin analogue (insulin aspart), measuring for six months in the blood of a substance termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:26:51 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:26:51 | INFO | valid | epoch 019 | valid on 'valid' subset | loss 2.742 | nll_loss 0.871 | ppl 1.83 | bleu 78.51 | wps 929.6 | wpb 1083 | bsz 37.8 | num_updates 2637 | best_loss 2.654
2021-02-01 00:26:51 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:26:57 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 19 @ 2637 updates, score 2.742) (writing took 6.5751713970676064 seconds)
2021-02-01 00:26:57 | INFO | fairseq_cli.train | end of epoch 19 (average epoch stats below)
2021-02-01 00:26:57 | INFO | train | epoch 019 | loss 2.124 | nll_loss 0.242 | ppl 1.18 | wps 9836.9 | ups 4 | wpb 2458.3 | bsz 71.9 | num_updates 2637 | lr 0.000115369 | gnorm 1.152 | loss_scale 8 | train_wall 23 | wall 796
2021-02-01 00:26:57 | INFO | fairseq_cli.train | begin training epoch 19
2021-02-01 00:27:08 | INFO | train_inner | epoch 020:     63 / 139 loss=2.108, nll_loss=0.227, ppl=1.17, wps=8464.7, ups=3.58, wpb=2364.7, bsz=73.9, num_updates=2700, lr=0.000118125, gnorm=1.028, loss_scale=8, train_wall=17, wall=806
2021-02-01 00:27:21 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:27:22 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:27:22 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:27:23 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in conjunction with long- acting insulin preparations.
2021-02-01 00:27:23 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:27:24 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:27:24 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:27:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetic patients, when the body cannot process insulin effectively (one study involving 182 patients) The studies compared Actrapide with a human insulin analogue (insulin aspart) by measuring the level in the blood of a substance, termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:27:26 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:27:26 | INFO | valid | epoch 020 | valid on 'valid' subset | loss 2.74 | nll_loss 0.885 | ppl 1.85 | bleu 78.42 | wps 906.8 | wpb 1083 | bsz 37.8 | num_updates 2776 | best_loss 2.654
2021-02-01 00:27:26 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:27:32 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 20 @ 2776 updates, score 2.74) (writing took 6.089439446106553 seconds)
2021-02-01 00:27:32 | INFO | fairseq_cli.train | end of epoch 20 (average epoch stats below)
2021-02-01 00:27:32 | INFO | train | epoch 020 | loss 2.113 | nll_loss 0.231 | ppl 1.17 | wps 9939.5 | ups 4.04 | wpb 2458.3 | bsz 71.9 | num_updates 2776 | lr 0.00012145 | gnorm 1.045 | loss_scale 8 | train_wall 23 | wall 830
2021-02-01 00:27:32 | INFO | fairseq_cli.train | begin training epoch 20
2021-02-01 00:27:36 | INFO | train_inner | epoch 021:     24 / 139 loss=2.126, nll_loss=0.244, ppl=1.18, wps=8806.9, ups=3.61, wpb=2437.6, bsz=64.6, num_updates=2800, lr=0.0001225, gnorm=1.259, loss_scale=8, train_wall=17, wall=834
2021-02-01 00:27:53 | INFO | train_inner | epoch 021:    124 / 139 loss=2.102, nll_loss=0.221, ppl=1.17, wps=14844, ups=5.88, wpb=2522.9, bsz=77, num_updates=2900, lr=0.000126875, gnorm=0.899, loss_scale=8, train_wall=17, wall=851
2021-02-01 00:27:55 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:27:56 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:27:56 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:27:57 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used in conjunction with long- acting insulin preparations.
2021-02-01 00:27:57 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:27:58 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:27:58 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:28:00 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, when the body cannot process insulin effectively (a study involving 182 patients) The studies compared Actrapide to a human insulin analogue (insulin aspart) by measuring the level in the blood of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:28:00 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:28:00 | INFO | valid | epoch 021 | valid on 'valid' subset | loss 2.747 | nll_loss 0.891 | ppl 1.85 | bleu 77.89 | wps 895.6 | wpb 1083 | bsz 37.8 | num_updates 2915 | best_loss 2.654
2021-02-01 00:28:00 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:28:07 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 21 @ 2915 updates, score 2.747) (writing took 6.7223604479804635 seconds)
2021-02-01 00:28:07 | INFO | fairseq_cli.train | end of epoch 21 (average epoch stats below)
2021-02-01 00:28:07 | INFO | train | epoch 021 | loss 2.112 | nll_loss 0.23 | ppl 1.17 | wps 9755.1 | ups 3.97 | wpb 2458.3 | bsz 71.9 | num_updates 2915 | lr 0.000127531 | gnorm 1.055 | loss_scale 8 | train_wall 23 | wall 865
2021-02-01 00:28:07 | INFO | fairseq_cli.train | begin training epoch 21
2021-02-01 00:28:21 | INFO | train_inner | epoch 022:     85 / 139 loss=2.1, nll_loss=0.217, ppl=1.16, wps=8612.4, ups=3.51, wpb=2455.5, bsz=70.6, num_updates=3000, lr=0.00013125, gnorm=0.93, loss_scale=8, train_wall=17, wall=880
2021-02-01 00:28:30 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:28:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:28:31 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:28:32 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be administered concomitantly with long- acting insulin preparations.
2021-02-01 00:28:32 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:28:33 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:28:33 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:28:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide was studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies of 1,954 patients), and in patients with type 2 diabetes, when the body cannot effectively process insulin (one study of 182 patients) The studies compared Actrapide with human insulin analogue (insulin aspart) by measuring, for six months, the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:28:35 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:28:35 | INFO | valid | epoch 022 | valid on 'valid' subset | loss 2.771 | nll_loss 0.915 | ppl 1.89 | bleu 78.24 | wps 894.7 | wpb 1083 | bsz 37.8 | num_updates 3054 | best_loss 2.654
2021-02-01 00:28:35 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:28:41 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 22 @ 3054 updates, score 2.771) (writing took 5.8032366670668125 seconds)
2021-02-01 00:28:41 | INFO | fairseq_cli.train | end of epoch 22 (average epoch stats below)
2021-02-01 00:28:41 | INFO | train | epoch 022 | loss 2.103 | nll_loss 0.221 | ppl 1.17 | wps 10008.4 | ups 4.07 | wpb 2458.3 | bsz 71.9 | num_updates 3054 | lr 0.000133613 | gnorm 1.057 | loss_scale 8 | train_wall 23 | wall 899
2021-02-01 00:28:41 | INFO | fairseq_cli.train | begin training epoch 22
2021-02-01 00:28:49 | INFO | train_inner | epoch 023:     46 / 139 loss=2.118, nll_loss=0.236, ppl=1.18, wps=8870.8, ups=3.63, wpb=2442.1, bsz=74, num_updates=3100, lr=0.000135625, gnorm=1.271, loss_scale=8, train_wall=17, wall=907
2021-02-01 00:29:05 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:29:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:29:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:29:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:29:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:29:07 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:29:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:29:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, when the body cannot effectively process insulin (a study in 182 patients).
2021-02-01 00:29:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:29:09 | INFO | valid | epoch 023 | valid on 'valid' subset | loss 2.791 | nll_loss 0.933 | ppl 1.91 | bleu 78.74 | wps 890.3 | wpb 1083 | bsz 37.8 | num_updates 3193 | best_loss 2.654
2021-02-01 00:29:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:29:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 23 @ 3193 updates, score 2.791) (writing took 6.498140615411103 seconds)
2021-02-01 00:29:16 | INFO | fairseq_cli.train | end of epoch 23 (average epoch stats below)
2021-02-01 00:29:16 | INFO | train | epoch 023 | loss 2.107 | nll_loss 0.226 | ppl 1.17 | wps 9788.4 | ups 3.98 | wpb 2458.3 | bsz 71.9 | num_updates 3193 | lr 0.000139694 | gnorm 1.03 | loss_scale 8 | train_wall 23 | wall 934
2021-02-01 00:29:16 | INFO | fairseq_cli.train | begin training epoch 23
2021-02-01 00:29:17 | INFO | train_inner | epoch 024:      7 / 139 loss=2.097, nll_loss=0.216, ppl=1.16, wps=8692.6, ups=3.54, wpb=2457, bsz=69.3, num_updates=3200, lr=0.00014, gnorm=0.9, loss_scale=8, train_wall=17, wall=935
2021-02-01 00:29:34 | INFO | train_inner | epoch 024:    107 / 139 loss=2.112, nll_loss=0.231, ppl=1.17, wps=14650.4, ups=5.86, wpb=2498.6, bsz=74.9, num_updates=3300, lr=0.000144375, gnorm=1.038, loss_scale=8, train_wall=17, wall=952
2021-02-01 00:29:40 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:29:40 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:29:40 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:29:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given together with long- acting insulin preparations.
2021-02-01 00:29:41 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:29:42 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:29:42 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:29:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in patients with type 2 diabetes, when the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:29:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:29:44 | INFO | valid | epoch 024 | valid on 'valid' subset | loss 2.794 | nll_loss 0.925 | ppl 1.9 | bleu 79.07 | wps 937.3 | wpb 1083 | bsz 37.8 | num_updates 3332 | best_loss 2.654
2021-02-01 00:29:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:29:50 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 24 @ 3332 updates, score 2.794) (writing took 6.098756777122617 seconds)
2021-02-01 00:29:50 | INFO | fairseq_cli.train | end of epoch 24 (average epoch stats below)
2021-02-01 00:29:50 | INFO | train | epoch 024 | loss 2.113 | nll_loss 0.232 | ppl 1.17 | wps 9954.8 | ups 4.05 | wpb 2458.3 | bsz 71.9 | num_updates 3332 | lr 0.000145775 | gnorm 1.156 | loss_scale 8 | train_wall 23 | wall 968
2021-02-01 00:29:50 | INFO | fairseq_cli.train | begin training epoch 24
2021-02-01 00:30:02 | INFO | train_inner | epoch 025:     68 / 139 loss=2.119, nll_loss=0.237, ppl=1.18, wps=8698.6, ups=3.65, wpb=2379.9, bsz=71, num_updates=3400, lr=0.00014875, gnorm=1.271, loss_scale=8, train_wall=17, wall=980
2021-02-01 00:30:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:30:14 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:30:14 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:30:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given concomitantly with long-acting insulin preparations.
2021-02-01 00:30:15 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:30:17 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:30:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:30:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients), and in type 2 diabetes, when the body cannot process insulin effectively (a study involving 182 patients).
2021-02-01 00:30:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:30:19 | INFO | valid | epoch 025 | valid on 'valid' subset | loss 2.779 | nll_loss 0.919 | ppl 1.89 | bleu 79.29 | wps 889.3 | wpb 1083 | bsz 37.8 | num_updates 3471 | best_loss 2.654
2021-02-01 00:30:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:30:25 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 25 @ 3471 updates, score 2.779) (writing took 6.59316654317081 seconds)
2021-02-01 00:30:25 | INFO | fairseq_cli.train | end of epoch 25 (average epoch stats below)
2021-02-01 00:30:25 | INFO | train | epoch 025 | loss 2.104 | nll_loss 0.224 | ppl 1.17 | wps 9764.5 | ups 3.97 | wpb 2458.3 | bsz 71.9 | num_updates 3471 | lr 0.000151856 | gnorm 1.002 | loss_scale 8 | train_wall 23 | wall 1003
2021-02-01 00:30:25 | INFO | fairseq_cli.train | begin training epoch 25
2021-02-01 00:30:30 | INFO | train_inner | epoch 026:     29 / 139 loss=2.091, nll_loss=0.211, ppl=1.16, wps=8718.4, ups=3.5, wpb=2488.4, bsz=68.1, num_updates=3500, lr=0.000153125, gnorm=0.878, loss_scale=8, train_wall=17, wall=1008
2021-02-01 00:30:47 | INFO | train_inner | epoch 026:    129 / 139 loss=2.107, nll_loss=0.227, ppl=1.17, wps=14566.8, ups=5.87, wpb=2483.1, bsz=73.9, num_updates=3600, lr=0.0001575, gnorm=1.222, loss_scale=8, train_wall=17, wall=1025
2021-02-01 00:30:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:30:49 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:30:49 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:30:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given together with long- acting insulin preparations.
2021-02-01 00:30:50 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:30:51 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:30:51 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:30:53 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients who the pancreas cannot produce insulin (two studies of 1,954 patients) and type 2 diabetes patients who the body cannot process insulin effectively (a study of 182 patients).
2021-02-01 00:30:53 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:30:53 | INFO | valid | epoch 026 | valid on 'valid' subset | loss 2.782 | nll_loss 0.913 | ppl 1.88 | bleu 80.41 | wps 976 | wpb 1083 | bsz 37.8 | num_updates 3610 | best_loss 2.654
2021-02-01 00:30:53 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:31:00 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 26 @ 3610 updates, score 2.782) (writing took 7.1809270875528455 seconds)
2021-02-01 00:31:00 | INFO | fairseq_cli.train | end of epoch 26 (average epoch stats below)
2021-02-01 00:31:00 | INFO | train | epoch 026 | loss 2.102 | nll_loss 0.222 | ppl 1.17 | wps 9703.4 | ups 3.95 | wpb 2458.3 | bsz 71.9 | num_updates 3610 | lr 0.000157937 | gnorm 1.13 | loss_scale 8 | train_wall 23 | wall 1039
2021-02-01 00:31:00 | INFO | fairseq_cli.train | begin training epoch 26
2021-02-01 00:31:16 | INFO | train_inner | epoch 027:     90 / 139 loss=2.097, nll_loss=0.217, ppl=1.16, wps=8716.8, ups=3.49, wpb=2497.2, bsz=72.2, num_updates=3700, lr=0.000161875, gnorm=0.973, loss_scale=8, train_wall=17, wall=1054
2021-02-01 00:31:24 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:31:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:31:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:31:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given together with long-acting insulin preparations.
2021-02-01 00:31:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:31:27 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:31:27 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:31:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies of 1,954 patients) and in patients with type 2 diabetes, when the body cannot effectively process insulin (a study of 182 patients). The studies compared Actrapapide to a human insulin analogue (insulin aspart) by measuring the concentration of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:31:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:31:29 | INFO | valid | epoch 027 | valid on 'valid' subset | loss 2.782 | nll_loss 0.925 | ppl 1.9 | bleu 78.97 | wps 827 | wpb 1083 | bsz 37.8 | num_updates 3749 | best_loss 2.654
2021-02-01 00:31:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:31:36 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 27 @ 3749 updates, score 2.782) (writing took 7.199188854545355 seconds)
2021-02-01 00:31:36 | INFO | fairseq_cli.train | end of epoch 27 (average epoch stats below)
2021-02-01 00:31:36 | INFO | train | epoch 027 | loss 2.103 | nll_loss 0.224 | ppl 1.17 | wps 9511.1 | ups 3.87 | wpb 2458.3 | bsz 71.9 | num_updates 3749 | lr 0.000164019 | gnorm 1.1 | loss_scale 8 | train_wall 23 | wall 1075
2021-02-01 00:31:36 | INFO | fairseq_cli.train | begin training epoch 27
2021-02-01 00:31:45 | INFO | train_inner | epoch 028:     51 / 139 loss=2.103, nll_loss=0.223, ppl=1.17, wps=8114, ups=3.43, wpb=2366.9, bsz=69.9, num_updates=3800, lr=0.00016625, gnorm=1.138, loss_scale=8, train_wall=17, wall=1083
2021-02-01 00:32:00 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:32:01 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:32:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:32:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:32:02 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:32:03 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:32:03 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:32:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been used in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies of 1,954 patients), and in patients with type 2 diabetes, when the body cannot effectively process insulin (a study of 182 patients). The studies compared Actrapide to a human insulin analogue (insulin aspart) by measuring the level of a substance in the blood, called glycosylated haemoglobin (HbA1c), during six months of treatment with Actrapide.
2021-02-01 00:32:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:32:05 | INFO | valid | epoch 028 | valid on 'valid' subset | loss 2.762 | nll_loss 0.925 | ppl 1.9 | bleu 78.62 | wps 895.8 | wpb 1083 | bsz 37.8 | num_updates 3888 | best_loss 2.654
2021-02-01 00:32:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:32:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 28 @ 3888 updates, score 2.762) (writing took 6.208304605446756 seconds)
2021-02-01 00:32:11 | INFO | fairseq_cli.train | end of epoch 28 (average epoch stats below)
2021-02-01 00:32:11 | INFO | train | epoch 028 | loss 2.107 | nll_loss 0.226 | ppl 1.17 | wps 9881.5 | ups 4.02 | wpb 2458.3 | bsz 71.9 | num_updates 3888 | lr 0.0001701 | gnorm 1.144 | loss_scale 8 | train_wall 23 | wall 1109
2021-02-01 00:32:11 | INFO | fairseq_cli.train | begin training epoch 28
2021-02-01 00:32:13 | INFO | train_inner | epoch 029:     12 / 139 loss=2.113, nll_loss=0.233, ppl=1.18, wps=8906.2, ups=3.57, wpb=2495.8, bsz=74.3, num_updates=3900, lr=0.000170625, gnorm=1.223, loss_scale=8, train_wall=17, wall=1111
2021-02-01 00:32:28 | INFO | fairseq.trainer | NOTE: overflow detected, setting loss scale to: 4.0
2021-02-01 00:32:30 | INFO | train_inner | epoch 029:    113 / 139 loss=2.096, nll_loss=0.217, ppl=1.16, wps=14276.9, ups=5.9, wpb=2421.1, bsz=68.5, num_updates=4000, lr=0.000175, gnorm=0.997, loss_scale=7, train_wall=17, wall=1128
2021-02-01 00:32:35 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:32:35 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:32:35 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:32:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used concomitantly with long-acting insulin preparations.
2021-02-01 00:32:36 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:32:37 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:32:37 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:32:39 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients who the pancreas cannot produce insulin (two studies of 1 954 patients) and in type 2 diabetic patients in whom the body cannot effectively process insulin (a study of 182 patients).
2021-02-01 00:32:39 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:32:39 | INFO | valid | epoch 029 | valid on 'valid' subset | loss 2.785 | nll_loss 0.926 | ppl 1.9 | bleu 79.27 | wps 899 | wpb 1083 | bsz 37.8 | num_updates 4026 | best_loss 2.654
2021-02-01 00:32:39 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:32:52 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 29 @ 4026 updates, score 2.785) (writing took 13.030158773064613 seconds)
2021-02-01 00:32:52 | INFO | fairseq_cli.train | end of epoch 29 (average epoch stats below)
2021-02-01 00:32:52 | INFO | train | epoch 029 | loss 2.096 | nll_loss 0.217 | ppl 1.16 | wps 8252.3 | ups 3.34 | wpb 2471.8 | bsz 72.5 | num_updates 4026 | lr 0.000174434 | gnorm 0.957 | loss_scale 7 | train_wall 23 | wall 1150
2021-02-01 00:32:52 | INFO | fairseq_cli.train | begin training epoch 29
2021-02-01 00:33:05 | INFO | train_inner | epoch 030:     74 / 139 loss=2.101, nll_loss=0.222, ppl=1.17, wps=7129.8, ups=2.88, wpb=2479, bsz=78.1, num_updates=4100, lr=0.000172853, gnorm=0.962, loss_scale=4, train_wall=17, wall=1163
2021-02-01 00:33:16 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:33:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:33:16 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:33:17 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin that can be given in combination with long-acting insulin preparations.
2021-02-01 00:33:17 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:33:19 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:33:19 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:33:21 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients when the pancreas cannot produce insulin (two studies of 1,954 patients) and type 2 diabetes patients when the body cannot effectively process insulin (a study of 182 patients). In the studies, Actrapide was compared to a human insulin analogue (insulin aspart) when the level of a substance in the blood, termed glycosylated haemoglobin (HbA1c), which showed how well the blood glucose is controlled.
2021-02-01 00:33:21 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:33:21 | INFO | valid | epoch 030 | valid on 'valid' subset | loss 2.83 | nll_loss 0.982 | ppl 1.97 | bleu 79.97 | wps 874.5 | wpb 1083 | bsz 37.8 | num_updates 4165 | best_loss 2.654
2021-02-01 00:33:21 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:33:27 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 30 @ 4165 updates, score 2.83) (writing took 6.030391342006624 seconds)
2021-02-01 00:33:27 | INFO | fairseq_cli.train | end of epoch 30 (average epoch stats below)
2021-02-01 00:33:27 | INFO | train | epoch 030 | loss 2.1 | nll_loss 0.221 | ppl 1.17 | wps 9916.9 | ups 4.03 | wpb 2458.3 | bsz 71.9 | num_updates 4165 | lr 0.000171499 | gnorm 1.031 | loss_scale 4 | train_wall 23 | wall 1185
2021-02-01 00:33:27 | INFO | fairseq_cli.train | begin training epoch 30
2021-02-01 00:33:33 | INFO | train_inner | epoch 031:     35 / 139 loss=2.091, nll_loss=0.212, ppl=1.16, wps=8901.8, ups=3.58, wpb=2486, bsz=71.4, num_updates=4200, lr=0.000170783, gnorm=0.947, loss_scale=4, train_wall=17, wall=1191
2021-02-01 00:33:50 | INFO | train_inner | epoch 031:    135 / 139 loss=2.1, nll_loss=0.221, ppl=1.17, wps=14511, ups=5.9, wpb=2459.9, bsz=71.8, num_updates=4300, lr=0.000168785, gnorm=1.127, loss_scale=4, train_wall=17, wall=1208
2021-02-01 00:33:50 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:33:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:33:51 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:33:52 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is fast-acting insulin and can be given together with long-acting insulin preparations.
2021-02-01 00:33:52 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:33:53 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:33:53 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:33:55 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies, involving 1,954 patients) and in patients with type 2 diabetes, when the body cannot effectively process insulin (a study involving 182 patients) and the studies compared Actrapide with a human analogue (insulin aspart) when Actrapide concentration in the blood, termed glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
2021-02-01 00:33:55 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:33:55 | INFO | valid | epoch 031 | valid on 'valid' subset | loss 2.855 | nll_loss 1.008 | ppl 2.01 | bleu 78.95 | wps 892.7 | wpb 1083 | bsz 37.8 | num_updates 4304 | best_loss 2.654
2021-02-01 00:33:55 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:34:02 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 31 @ 4304 updates, score 2.855) (writing took 6.919744691811502 seconds)
2021-02-01 00:34:02 | INFO | fairseq_cli.train | end of epoch 31 (average epoch stats below)
2021-02-01 00:34:02 | INFO | train | epoch 031 | loss 2.095 | nll_loss 0.215 | ppl 1.16 | wps 9675 | ups 3.94 | wpb 2458.3 | bsz 71.9 | num_updates 4304 | lr 0.000168707 | gnorm 1.041 | loss_scale 4 | train_wall 23 | wall 1220
2021-02-01 00:34:02 | INFO | fairseq_cli.train | begin training epoch 31
2021-02-01 00:34:18 | INFO | train_inner | epoch 032:     96 / 139 loss=2.113, nll_loss=0.235, ppl=1.18, wps=8526, ups=3.5, wpb=2437.2, bsz=68.2, num_updates=4400, lr=0.000166856, gnorm=1.508, loss_scale=4, train_wall=17, wall=1236
2021-02-01 00:34:26 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:34:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:34:26 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:34:27 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given together with long- acting insulin preparations.
2021-02-01 00:34:27 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:34:28 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:34:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:34:31 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetes patients, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetes patients, when the body cannot use insulin effectively (a study involving 182 patients).
2021-02-01 00:34:31 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:34:31 | INFO | valid | epoch 032 | valid on 'valid' subset | loss 2.81 | nll_loss 0.967 | ppl 1.95 | bleu 79.62 | wps 865 | wpb 1083 | bsz 37.8 | num_updates 4443 | best_loss 2.654
2021-02-01 00:34:31 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:34:40 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 32 @ 4443 updates, score 2.81) (writing took 9.832659045234323 seconds)
2021-02-01 00:34:40 | INFO | fairseq_cli.train | end of epoch 32 (average epoch stats below)
2021-02-01 00:34:40 | INFO | train | epoch 032 | loss 2.105 | nll_loss 0.227 | ppl 1.17 | wps 8911.6 | ups 3.63 | wpb 2458.3 | bsz 71.9 | num_updates 4443 | lr 0.000166047 | gnorm 1.307 | loss_scale 4 | train_wall 23 | wall 1259
2021-02-01 00:34:40 | INFO | fairseq_cli.train | begin training epoch 32
2021-02-01 00:34:50 | INFO | train_inner | epoch 033:     57 / 139 loss=2.083, nll_loss=0.205, ppl=1.15, wps=7784.9, ups=3.15, wpb=2470.2, bsz=77.6, num_updates=4500, lr=0.000164992, gnorm=0.795, loss_scale=4, train_wall=17, wall=1268
2021-02-01 00:35:04 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:35:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:35:05 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:35:06 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be given together with long-acting insulin preparations.
2021-02-01 00:35:06 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:35:07 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:35:07 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:35:09 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide was studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes, when the body cannot process insulin effectively (a study of 182 patients).
2021-02-01 00:35:09 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:35:09 | INFO | valid | epoch 033 | valid on 'valid' subset | loss 2.828 | nll_loss 0.988 | ppl 1.98 | bleu 78.44 | wps 947.5 | wpb 1083 | bsz 37.8 | num_updates 4582 | best_loss 2.654
2021-02-01 00:35:09 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:35:16 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 33 @ 4582 updates, score 2.828) (writing took 7.630383417010307 seconds)
2021-02-01 00:35:16 | INFO | fairseq_cli.train | end of epoch 33 (average epoch stats below)
2021-02-01 00:35:16 | INFO | train | epoch 033 | loss 2.087 | nll_loss 0.21 | ppl 1.16 | wps 9540.2 | ups 3.88 | wpb 2458.3 | bsz 71.9 | num_updates 4582 | lr 0.000163509 | gnorm 0.906 | loss_scale 4 | train_wall 23 | wall 1294
2021-02-01 00:35:16 | INFO | fairseq_cli.train | begin training epoch 33
2021-02-01 00:35:19 | INFO | train_inner | epoch 034:     18 / 139 loss=2.091, nll_loss=0.215, ppl=1.16, wps=8326.1, ups=3.41, wpb=2439.5, bsz=68.4, num_updates=4600, lr=0.000163188, gnorm=1.065, loss_scale=4, train_wall=17, wall=1297
2021-02-01 00:35:36 | INFO | train_inner | epoch 034:    118 / 139 loss=2.089, nll_loss=0.212, ppl=1.16, wps=14343, ups=5.93, wpb=2417.6, bsz=70.1, num_updates=4700, lr=0.000161443, gnorm=1.153, loss_scale=4, train_wall=17, wall=1314
2021-02-01 00:35:40 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:35:40 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:35:40 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:35:41 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:35:41 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:35:42 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:35:42 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:35:44 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes, when the body cannot use insulin effectively (one study involving 182 patients) The studies compared Actrapide with a human insulin analogue (insulin aspart), by measuring the concentration in the blood of a substance termed glycosylated haemoglobin (HbA1c), indicating how well the blood glucose has been controlled.
2021-02-01 00:35:44 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:35:44 | INFO | valid | epoch 034 | valid on 'valid' subset | loss 2.837 | nll_loss 0.987 | ppl 1.98 | bleu 78.95 | wps 941.5 | wpb 1083 | bsz 37.8 | num_updates 4721 | best_loss 2.654
2021-02-01 00:35:44 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:35:50 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 34 @ 4721 updates, score 2.837) (writing took 6.132775703445077 seconds)
2021-02-01 00:35:50 | INFO | fairseq_cli.train | end of epoch 34 (average epoch stats below)
2021-02-01 00:35:50 | INFO | train | epoch 034 | loss 2.089 | nll_loss 0.212 | ppl 1.16 | wps 9965 | ups 4.05 | wpb 2458.3 | bsz 71.9 | num_updates 4721 | lr 0.000161083 | gnorm 1.154 | loss_scale 4 | train_wall 23 | wall 1329
2021-02-01 00:35:50 | INFO | fairseq_cli.train | begin training epoch 34
2021-02-01 00:36:04 | INFO | train_inner | epoch 035:     79 / 139 loss=2.082, nll_loss=0.207, ppl=1.15, wps=8978.7, ups=3.61, wpb=2489.1, bsz=72.8, num_updates=4800, lr=0.000159752, gnorm=0.885, loss_scale=4, train_wall=17, wall=1342
2021-02-01 00:36:14 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:36:15 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:15 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:16 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be administered together with long-acting insulin preparations.
2021-02-01 00:36:16 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:36:17 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:17 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:19 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide was studied in patients with type 1 diabetes, when the pancreas cannot produce insulin, (two studies involving 1,954 patients) and in type 2 diabetes patients, when the body cannot effectively process insulin (a study in 182 patients).
2021-02-01 00:36:19 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:36:19 | INFO | valid | epoch 035 | valid on 'valid' subset | loss 2.862 | nll_loss 1.027 | ppl 2.04 | bleu 78.79 | wps 899.6 | wpb 1083 | bsz 37.8 | num_updates 4860 | best_loss 2.654
2021-02-01 00:36:19 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:36:26 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 35 @ 4860 updates, score 2.862) (writing took 7.0415720688179135 seconds)
2021-02-01 00:36:26 | INFO | fairseq_cli.train | end of epoch 35 (average epoch stats below)
2021-02-01 00:36:26 | INFO | train | epoch 035 | loss 2.082 | nll_loss 0.206 | ppl 1.15 | wps 9666.1 | ups 3.93 | wpb 2458.3 | bsz 71.9 | num_updates 4860 | lr 0.000158763 | gnorm 1.762 | loss_scale 4 | train_wall 23 | wall 1364
2021-02-01 00:36:26 | INFO | fairseq_cli.train | begin training epoch 35
2021-02-01 00:36:33 | INFO | train_inner | epoch 036:     40 / 139 loss=2.084, nll_loss=0.209, ppl=1.16, wps=8533.6, ups=3.47, wpb=2458, bsz=71.5, num_updates=4900, lr=0.000158114, gnorm=2.236, loss_scale=4, train_wall=17, wall=1371
2021-02-01 00:36:49 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:36:50 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:50 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:36:51 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be administered together with long-acting insulin preparations.
2021-02-01 00:36:51 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:36:52 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:52 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:36:54 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes, when the body cannot effectively process insulin (a study involving 182 patients).
2021-02-01 00:36:54 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:36:54 | INFO | valid | epoch 036 | valid on 'valid' subset | loss 2.822 | nll_loss 1.003 | ppl 2 | bleu 79.78 | wps 903.5 | wpb 1083 | bsz 37.8 | num_updates 4999 | best_loss 2.654
2021-02-01 00:36:54 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:37:01 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 36 @ 4999 updates, score 2.822) (writing took 6.910005908459425 seconds)
2021-02-01 00:37:01 | INFO | fairseq_cli.train | end of epoch 36 (average epoch stats below)
2021-02-01 00:37:01 | INFO | train | epoch 036 | loss 2.076 | nll_loss 0.2 | ppl 1.15 | wps 9689.8 | ups 3.94 | wpb 2458.3 | bsz 71.9 | num_updates 4999 | lr 0.00015654 | gnorm 0.876 | loss_scale 4 | train_wall 23 | wall 1399
2021-02-01 00:37:01 | INFO | fairseq_cli.train | begin training epoch 36
2021-02-01 00:37:01 | INFO | train_inner | epoch 037:      1 / 139 loss=2.071, nll_loss=0.195, ppl=1.14, wps=8701.1, ups=3.49, wpb=2490.8, bsz=73.8, num_updates=5000, lr=0.000156525, gnorm=0.772, loss_scale=4, train_wall=17, wall=1400
2021-02-01 00:37:18 | INFO | train_inner | epoch 037:    101 / 139 loss=2.065, nll_loss=0.19, ppl=1.14, wps=14290.2, ups=5.89, wpb=2427, bsz=70.5, num_updates=5100, lr=0.000154983, gnorm=0.694, loss_scale=4, train_wall=17, wall=1416
2021-02-01 00:37:25 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:37:25 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:37:25 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:37:26 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:37:26 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:37:28 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:37:28 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:37:29 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been studied in type 1 diabetic patients who cannot produce insulin (two studies involving 1,954 patients) and in type 2 diabetic patients who cannot effectively process insulin (a study of 182 patients). in the studies, Actrapide was compared with a human insulin analogue (insulin aspart), by having six months of concentration in the blood of a substance in the blood called glycosylated haemoglobin (HbA1c), which showed how well the blood glucose is controlled.
2021-02-01 00:37:29 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:37:29 | INFO | valid | epoch 037 | valid on 'valid' subset | loss 2.837 | nll_loss 1.004 | ppl 2.01 | bleu 80.14 | wps 912.1 | wpb 1083 | bsz 37.8 | num_updates 5138 | best_loss 2.654
2021-02-01 00:37:29 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:37:36 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 37 @ 5138 updates, score 2.837) (writing took 6.9028386091813445 seconds)
2021-02-01 00:37:36 | INFO | fairseq_cli.train | end of epoch 37 (average epoch stats below)
2021-02-01 00:37:36 | INFO | train | epoch 037 | loss 2.066 | nll_loss 0.191 | ppl 1.14 | wps 9707.3 | ups 3.95 | wpb 2458.3 | bsz 71.9 | num_updates 5138 | lr 0.000154408 | gnorm 0.717 | loss_scale 4 | train_wall 23 | wall 1434
2021-02-01 00:37:36 | INFO | fairseq_cli.train | begin training epoch 37
2021-02-01 00:37:47 | INFO | train_inner | epoch 038:     62 / 139 loss=2.07, nll_loss=0.196, ppl=1.15, wps=8553.2, ups=3.52, wpb=2427.7, bsz=73, num_updates=5200, lr=0.000153485, gnorm=0.747, loss_scale=4, train_wall=17, wall=1445
2021-02-01 00:38:00 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:38:01 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:01 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:02 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long- acting insulin preparations.
2021-02-01 00:38:02 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:38:03 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:03 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:05 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide has been used in patients with type 1 diabetes, when the pancreas cannot produce insulin (two studies involving 1,954 patients) and in patients with type 2 diabetes, when the body cannot use insulin effectively (a study of 182 patients).
2021-02-01 00:38:05 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:38:05 | INFO | valid | epoch 038 | valid on 'valid' subset | loss 2.821 | nll_loss 1.003 | ppl 2 | bleu 78.21 | wps 879.4 | wpb 1083 | bsz 37.8 | num_updates 5277 | best_loss 2.654
2021-02-01 00:38:05 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:38:11 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 38 @ 5277 updates, score 2.821) (writing took 6.723842781968415 seconds)
2021-02-01 00:38:11 | INFO | fairseq_cli.train | end of epoch 38 (average epoch stats below)
2021-02-01 00:38:11 | INFO | train | epoch 038 | loss 2.07 | nll_loss 0.196 | ppl 1.15 | wps 9721.7 | ups 3.95 | wpb 2458.3 | bsz 71.9 | num_updates 5277 | lr 0.000152361 | gnorm 0.813 | loss_scale 4 | train_wall 23 | wall 1470
2021-02-01 00:38:11 | INFO | fairseq_cli.train | begin training epoch 38
2021-02-01 00:38:16 | INFO | train_inner | epoch 039:     23 / 139 loss=2.067, nll_loss=0.193, ppl=1.14, wps=8980, ups=3.46, wpb=2593.3, bsz=74.2, num_updates=5300, lr=0.00015203, gnorm=0.857, loss_scale=4, train_wall=17, wall=1474
2021-02-01 00:38:32 | INFO | train_inner | epoch 039:    123 / 139 loss=2.067, nll_loss=0.192, ppl=1.14, wps=14204.8, ups=5.91, wpb=2401.7, bsz=70.7, num_updates=5400, lr=0.000150616, gnorm=0.679, loss_scale=4, train_wall=17, wall=1491
2021-02-01 00:38:35 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:38:36 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:36 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:38:37 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:38:37 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:38:38 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:38 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:38:40 | INFO | fairseq.tasks.translation | example hypothesis: The concentrations of HbA1c in these studies were relative stable during the 6 months of treatment with Actrapide.
2021-02-01 00:38:40 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:38:40 | INFO | valid | epoch 039 | valid on 'valid' subset | loss 2.816 | nll_loss 0.987 | ppl 1.98 | bleu 79.51 | wps 932.7 | wpb 1083 | bsz 37.8 | num_updates 5416 | best_loss 2.654
2021-02-01 00:38:40 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:38:47 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 39 @ 5416 updates, score 2.816) (writing took 7.054796636104584 seconds)
2021-02-01 00:38:47 | INFO | fairseq_cli.train | end of epoch 39 (average epoch stats below)
2021-02-01 00:38:47 | INFO | train | epoch 039 | loss 2.064 | nll_loss 0.19 | ppl 1.14 | wps 9703.7 | ups 3.95 | wpb 2458.3 | bsz 71.9 | num_updates 5416 | lr 0.000150393 | gnorm 0.698 | loss_scale 4 | train_wall 23 | wall 1505
2021-02-01 00:38:47 | INFO | fairseq_cli.train | begin training epoch 39
2021-02-01 00:39:01 | INFO | train_inner | epoch 040:     84 / 139 loss=2.065, nll_loss=0.191, ppl=1.14, wps=8504.1, ups=3.51, wpb=2423.4, bsz=72, num_updates=5500, lr=0.000149241, gnorm=0.734, loss_scale=4, train_wall=17, wall=1519
2021-02-01 00:39:10 | INFO | fairseq_cli.train | begin validation on "valid" subset
2021-02-01 00:39:11 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide contains metacresol, which may cause allergic reactions.
2021-02-01 00:39:11 | INFO | fairseq.tasks.translation | example reference: Actrapid contains metacresol, which may cause allergic reactions.
2021-02-01 00:39:12 | INFO | fairseq.tasks.translation | example hypothesis: Actrapide is a fast-acting insulin and can be used together with long-acting insulin preparations.
2021-02-01 00:39:12 | INFO | fairseq.tasks.translation | example reference: Actrapid is a fast-acting insulin and may be used with long-acting insulins.
2021-02-01 00:39:13 | INFO | fairseq.tasks.translation | example hypothesis: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:39:13 | INFO | fairseq.tasks.translation | example reference: Nervous system disorders Uncommon - Peripheral neuropathy Fast improvement in blood glucose control may be associated with a condition termed acute painful neuropathy, which is usually reversible.
2021-02-01 00:39:15 | INFO | fairseq.tasks.translation | example hypothesis: During the 6 months of treatment with Actrapide, the concentrations of Actrapide in type 1 diabetes, when the pancreas cannot produce insulin (two studies of 1,954 patients) and in type 2 diabetes patients in whom the body cannot process insulin effectively (a study of 182 patients) were compared Actrapide with a human insulin analogue (insulin aspart), by measuring for six months the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which showed how well the blood glucose is controlled.
2021-02-01 00:39:15 | INFO | fairseq.tasks.translation | example reference: HbA1c levels remained fairly steady over the six months of treatment with Actrapid.
2021-02-01 00:39:15 | INFO | valid | epoch 040 | valid on 'valid' subset | loss 2.832 | nll_loss 1.019 | ppl 2.03 | bleu 78.35 | wps 865.5 | wpb 1083 | bsz 37.8 | num_updates 5555 | best_loss 2.654
2021-02-01 00:39:15 | INFO | fairseq_cli.train | begin save checkpoint
2021-02-01 00:39:23 | INFO | fairseq.checkpoint_utils | saved checkpoint ../checkpoints/EMEA_19/checkpoint_last.pt (epoch 40 @ 5555 updates, score 2.832) (writing took 7.477799949236214 seconds)
2021-02-01 00:39:23 | INFO | fairseq_cli.train | end of epoch 40 (average epoch stats below)
2021-02-01 00:39:23 | INFO | train | epoch 040 | loss 2.065 | nll_loss 0.191 | ppl 1.14 | wps 9476.2 | ups 3.85 | wpb 2458.3 | bsz 71.9 | num_updates 5555 | lr 0.0001485 | gnorm 0.712 | loss_scale 4 | train_wall 23 | wall 1541
2021-02-01 00:39:23 | INFO | fairseq_cli.train | done training in 1532.7 seconds


###############################################################################
Peregrine Cluster
Job 17761736 for user 's3475743'
Finished at: Mon Feb  1 00:39:28 CET 2021

Job details:
============

Job ID              : 17761736
Name                : EMEA_19
User                : s3475743
Partition           : gpu
Nodes               : pg-gpu31
Number of Nodes     : 1
Cores               : 12
State               : COMPLETED
Submit              : 2021-01-31T22:39:12
Start               : 2021-02-01T00:12:50
End                 : 2021-02-01T00:39:28
Reserved walltime   : 23:55:00
Used walltime       : 00:26:38
Used CPU time       : 00:25:43 (efficiency:  8.05%)
% User (Computation): 61.42%
% System (I/O)      : 38.58%
Mem reserved        : 32G/node
Max Mem used        : 5.60G (pg-gpu31)
Max Disk Write      : 40.96K (pg-gpu31)
Max Disk Read       : 2.30M (pg-gpu31)
Average GPU usage   : 60.1% (pg-gpu31)


Acknowledgements:
=================

Please see this page for information about acknowledging Peregrine in your publications:

https://wiki.hpc.rug.nl/peregrine/introduction/scientific_output

################################################################################
